DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2

Phase 1

Completed

Conditions: Pancreatic Neoplasms (Locally Advanced Non-metastatic)

Interventions: Drug: nab-paclitaxel
Radiation: 50.4Gy in 28#
Radiation: 60Gy in 30#
Drug: Nelfinavir
Drug: Capecitabine
Drug: Gemcitabine

First Posted Date: 2013-12-31

Last Posted Date: 2024-07-25

Lead Sponsor: University of Oxford

Target Recruit Count: 159

Registration Number: NCT02024009

Locations: 🇬🇧
University Hospitals Coventry and Warwickshire NHS Trust, University Hospital Coventry, Coventry, United Kingdom
🇬🇧
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom
🇬🇧
East Suffolk and North Essex NHS Foundation Trust, Colchester District General Hospital, Colchester, United Kingdom

and more 20 locations

Effectiveness of SMS-text Message Support for Patients With Hypertension to Improve Blood Pressure

Not Applicable

Completed

Conditions: Hypertension
SMS-text
mHealth

Interventions: Behavioral: Enhanced usual care
Behavioral: Informational SMS-text
Behavioral: Interactive SMS-text

First Posted Date: 2013-12-24

Last Posted Date: 2014-11-11

Lead Sponsor: University of Oxford

Target Recruit Count: 1372

Registration Number: NCT02019823

Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day

Phase 3

Completed

Conditions: Plasmodium Falciparum Infection

Interventions: Drug: Artemether-lumefantrine 5 days
Drug: Artemether-lumefantrine 3 days

First Posted Date: 2013-12-24

Last Posted Date: 2018-09-20

Lead Sponsor: University of Oxford

Target Recruit Count: 150

Registration Number: NCT02020330

Locations: 🇲🇲
Medical Action Myanmar, Yangon, Myanmar

Safety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza Vaccine

Phase 1

Terminated

Conditions: Influenza

Interventions: Biological: Viroflu® and MVA-NP+M1
Biological: Viroflu® and saline placebo

First Posted Date: 2013-12-18

Last Posted Date: 2014-04-30

Lead Sponsor: University of Oxford

Target Recruit Count: 3

Registration Number: NCT02014168

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, Oxfordshire, United Kingdom

A Study of the Interaction Between BCG And MenC Immunisation: BAM

Phase 4

Completed

Conditions: BCG Infection
Immune Response
Reaction - Vaccine

Interventions: Biological: NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix®
Biological: BCG, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix®

First Posted Date: 2013-12-05

Last Posted Date: 2018-10-18

Lead Sponsor: University of Oxford

Target Recruit Count: 28

Registration Number: NCT02002156

Locations: 🇬🇧
University of Oxford, Oxford Vaccine Group, Oxford, Oxfordshire, United Kingdom

Understanding Pneumococcal Carriage and Disease

Completed

Conditions: Pneumonia
Meningitis
Septicaemia

First Posted Date: 2013-11-27

Last Posted Date: 2019-07-08

Lead Sponsor: University of Oxford

Target Recruit Count: 1200

Registration Number: NCT01996007

Locations: 🇬🇧
Oxford Vaccine Group, Oxford, Oxfordshire, United Kingdom

Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception

Early Phase 1

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: placebo
Drug: d-cycloserine

First Posted Date: 2013-11-15

Last Posted Date: 2018-10-12

Lead Sponsor: University of Oxford

Target Recruit Count: 90

Registration Number: NCT01985750

Locations: 🇬🇧
Oxford Centre for Clinical Magnetic Resonance Imaging, Oxford, Oxfordshire, United Kingdom

Group B Streptococcus: Attitudes to Immunisation in Pregnancy

Completed

Conditions: Group B Streptococcus
Immunisation During Pregnancy

First Posted Date: 2013-11-13

Last Posted Date: 2018-04-05

Lead Sponsor: University of Oxford

Target Recruit Count: 758

Registration Number: NCT01982084

Locations: 🇬🇧
Edinburgh Royal Infirmary, Edinburgh, United Kingdom
🇬🇧
Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom
🇬🇧
Imperial College London, London, United Kingdom

and more 1 locations

Using Ultrasound to Predict the Results of Draining Pleural Effusions

Terminated

Conditions: Pleural Effusion

First Posted Date: 2013-11-01

Last Posted Date: 2018-01-10

Lead Sponsor: University of Oxford

Target Recruit Count: 2

Registration Number: NCT01973985

Locations: 🇬🇧
Churchill Hospital, Oxford, United Kingdom

Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector Immunity

Phase 1

Completed

Conditions: Tuberculosis

Interventions: Biological: MVA85A

First Posted Date: 2013-10-01

Last Posted Date: 2016-01-28

Lead Sponsor: University of Oxford

Target Recruit Count: 37

Registration Number: NCT01954563

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy